{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:09:21Z","timestamp":1771034961568,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Region \u00d6sterg\u00f6tland foundation"},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["K2015-99x-21874-05-4"],"award-info":[{"award-number":["K2015-99x-21874-05-4"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001861","name":"Forskningsr\u00e5det f\u00f6r Arbetsliv och Socialvetenskap","doi-asserted-by":"publisher","award":["2010-0913"],"award-info":[{"award-number":["2010-0913"]}],"id":[{"id":"10.13039\/501100001861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002706","name":"AFA F\u00f6rs\u00e4kring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0505-7","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T12:49:02Z","timestamp":1497271742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study"],"prefix":"10.1186","volume":"16","author":[{"given":"Niclas","family":"Stensson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijar","family":"Ghafouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Gerdle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazdar","family":"Ghafouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"issue":"1","key":"505_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","volume":"157","author":"KE Mansfield","year":"2016","unstructured":"Mansfield KE, et al. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157(1):55\u201364.","journal-title":"Pain"},{"issue":"4","key":"505_CR2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1521-6942(03)00042-1","volume":"17","author":"JT Gran","year":"2003","unstructured":"Gran JT. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol. 2003;17(4):547\u201361.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"505_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.berh.2010.01.010","volume":"25","author":"R Staud","year":"2011","unstructured":"Staud R. Peripheral pain mechanisms in chronic widespread pain. Best Pract Res Clin Rheumatol. 2011;25(2):155\u201364.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"505_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2474-11-42","volume":"11","author":"B Gerdle","year":"2010","unstructured":"Gerdle B, et al. Altered neuromuscular control mechanisms of the trapezius muscle in fibromyalgia. BMC Musculoskelet Disord. 2010;11:42.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1\u20132","key":"505_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3959(02)00053-2","volume":"99","author":"DD Price","year":"2002","unstructured":"Price DD, et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 2002;99(1\u20132):49\u201359.","journal-title":"Pain"},{"issue":"5","key":"505_CR6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.10893","volume":"48","author":"JA Desmeules","year":"2003","unstructured":"Desmeules JA, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 2003;48(5):1420\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"505_CR7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11916-008-0057-7","volume":"12","author":"JM DeSantana","year":"2008","unstructured":"DeSantana JM, Sluka KA. Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain. Curr Pain Headache Rep. 2008;12(5):338\u201343.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"505_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.22512","volume":"89","author":"DL Petersel","year":"2011","unstructured":"Petersel DL, Dror V, Cheung R. Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res. 2011;89(1):29\u201334.","journal-title":"J Neurosci Res"},{"key":"505_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-8069-8-32","volume":"8","author":"KB Jensen","year":"2012","unstructured":"Jensen KB, et al. Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain. 2012;8:32.","journal-title":"Mol Pain"},{"issue":"12 Suppl","key":"505_CR10","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","volume":"122","author":"LA Bradley","year":"2009","unstructured":"Bradley LA. Pathophysiology of fibromyalgia. Am J Med. 2009;122(12 Suppl):S22\u201330.","journal-title":"Am J Med"},{"issue":"2","key":"505_CR11","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.36076\/ppj.2011\/14\/E217","volume":"14","author":"H Smith","year":"2011","unstructured":"Smith H, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011;14(2):E217\u201345.","journal-title":"Pain Physician"},{"issue":"1\u20132","key":"505_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2009.05.020","volume":"145","author":"R Staud","year":"2009","unstructured":"Staud R, et al. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain. 2009;145(1\u20132):96\u2013104.","journal-title":"Pain"},{"issue":"2","key":"505_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.24065","volume":"75","author":"J Serra","year":"2014","unstructured":"Serra J, et al. Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol. 2014;75(2):196\u2013208.","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"505_CR14","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/brain\/awt053","volume":"136","author":"N Uceyler","year":"2013","unstructured":"Uceyler N, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain. 2013;136(Pt 6):1857\u201367.","journal-title":"Brain"},{"issue":"3","key":"505_CR15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13760-014-0411-y","volume":"115","author":"V Verma","year":"2015","unstructured":"Verma V, Sheikh Z, Ahmed AS. Nociception and role of immune system in pain. Acta Neurol Belg. 2015;115(3):213\u201320.","journal-title":"Acta Neurol Belg"},{"issue":"7","key":"505_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","volume":"6","author":"F Marchand","year":"2005","unstructured":"Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci. 2005;6(7):521\u201332.","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"505_CR17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.pain.2014.05.007","volume":"155","author":"E Generaal","year":"2014","unstructured":"Generaal E, et al. Basal inflammation and innate immune response in chronic multisite musculoskeletal pain. Pain. 2014;155(8):1605\u201312.","journal-title":"Pain"},{"issue":"1","key":"505_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","volume":"38","author":"FA Pinho-Ribeiro","year":"2017","unstructured":"Pinho-Ribeiro FA, Verri WA Jr, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017;38(1):5\u201319.","journal-title":"Trends Immunol"},{"issue":"7","key":"505_CR19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn3946","volume":"16","author":"SB McMahon","year":"2015","unstructured":"McMahon SB, La Russa F, Bennett DL. Crosstalk between the nociceptive and immune systems in host defence and disease. Nat Rev Neurosci. 2015;16(7):389\u2013402.","journal-title":"Nat Rev Neurosci"},{"key":"505_CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-319-20825-1_6","volume":"231","author":"GA Cabral","year":"2015","unstructured":"Cabral GA, Ferreira GA, Jamerson MJ. Endocannabinoids and the immune system in health and disease. Handb Exp Pharmacol. 2015;231:185\u2013211.","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"505_CR21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","volume":"52","author":"SD Skaper","year":"2015","unstructured":"Skaper SD, et al. N-Palmitoylethanolamine and Neuroinflammation: a novel therapeutic strategy of resolution. Mol Neurobiol. 2015;52(2):1034\u201342.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"505_CR22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","volume":"17","author":"D Piomelli","year":"2014","unstructured":"Piomelli D, Sasso O. Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci. 2014;17(2):164\u201374.","journal-title":"Nat Neurosci"},{"issue":"1","key":"505_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","volume":"67","author":"J Lo Verme","year":"2005","unstructured":"Lo Verme J, et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2005;67(1):15\u20139.","journal-title":"Mol Pharmacol"},{"issue":"10","key":"505_CR24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.drudis.2014.06.007","volume":"19","author":"M Alhouayek","year":"2014","unstructured":"Alhouayek M, Muccioli GG. Harnessing the anti-inflammatory potential of palmitoylethanolamide. Drug Discov Today. 2014;19(10):1632\u20139.","journal-title":"Drug Discov Today"},{"issue":"6860","key":"505_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","volume":"414","author":"F Rodriguez de Fonseca","year":"2001","unstructured":"Rodriguez de Fonseca F, et al. An anorexic lipid mediator regulated by feeding. Nature. 2001;414(6860):209\u201312.","journal-title":"Nature"},{"issue":"6953","key":"505_CR26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","volume":"425","author":"J Fu","year":"2003","unstructured":"Fu J, et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003;425(6953):90\u20133.","journal-title":"Nature"},{"issue":"1\u20133","key":"505_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pain.2007.03.008","volume":"133","author":"M Suardiaz","year":"2007","unstructured":"Suardiaz M, et al. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain. 2007;133(1\u20133):99\u2013110.","journal-title":"Pain"},{"issue":"Pt 2","key":"505_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1113\/jphysiol.2004.081844","volume":"564","author":"X Wang","year":"2005","unstructured":"Wang X, Miyares RL, Ahern GP. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J Physiol. 2005;564(Pt 2):541\u20137.","journal-title":"J Physiol"},{"issue":"46","key":"505_CR29","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1523\/JNEUROSCI.3475-14.2014","volume":"34","author":"D Piomelli","year":"2014","unstructured":"Piomelli D, et al. A lipid gate for the peripheral control of pain. J Neurosci. 2014;34(46):15184\u201391.","journal-title":"J Neurosci"},{"key":"505_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.prostaglandins.2015.05.001","volume":"121","author":"AG Berdyshev","year":"2015","unstructured":"Berdyshev AG, et al. N-Stearoylethanolamine suppresses the pro-inflammatory cytokines production by inhibition of NF-kappaB translocation. Prostaglandins Other Lipid Mediat. 2015;121:91.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"Suppl 1","key":"505_CR31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2826.2008.01689.x","volume":"20","author":"M Dalle Carbonare","year":"2008","unstructured":"Dalle Carbonare M, et al. A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story. J Neuroendocrinol. 2008;20(Suppl 1):26\u201334.","journal-title":"J Neuroendocrinol"},{"issue":"8","key":"505_CR32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1567-5769(02)00057-7","volume":"2","author":"X Zhang","year":"2002","unstructured":"Zhang X, Young HA. PPAR and immune system--what do we know? Int Immunopharmacol. 2002;2(8):1029\u201344.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"505_CR33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","volume":"1771","author":"M Ricote","year":"2007","unstructured":"Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta. 2007;1771(8):926\u201335.","journal-title":"Biochim Biophys Acta"},{"issue":"6662","key":"505_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote M, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391(6662):79\u201382.","journal-title":"Nature"},{"issue":"45","key":"505_CR35","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","volume":"274","author":"P Delerive","year":"1999","unstructured":"Delerive P, et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999;274(45):32048\u201354.","journal-title":"J Biol Chem"},{"issue":"6662","key":"505_CR36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","volume":"391","author":"C Jiang","year":"1998","unstructured":"Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391(6662):82\u20136.","journal-title":"Nature"},{"issue":"16","key":"505_CR37","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.1074\/jbc.M400346200","volume":"279","author":"P Gervois","year":"2004","unstructured":"Gervois P, et al. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. J Biol Chem. 2004;279(16):16154\u201360.","journal-title":"J Biol Chem"},{"key":"505_CR38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13075-015-0845-5","volume":"17","author":"T Lowin","year":"2015","unstructured":"Lowin T, et al. Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner. Arthritis Res Ther. 2015;17:321.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"505_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu111","volume":"18","author":"A Sayd","year":"2015","unstructured":"Sayd A, et al. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats. Int J Neuropsychopharmacol. 2015;18(6):1\u201314.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"505_CR40","first-page":"225","volume":"25","author":"L Bazzichi","year":"2007","unstructured":"Bazzichi L, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol. 2007;25(2):225\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"505_CR41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","volume":"84","author":"A Ranzolin","year":"2016","unstructured":"Ranzolin A, et al. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - a controlled cross-sectional study. Cytokine. 2016;84:25\u20138.","journal-title":"Cytokine"},{"key":"505_CR42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2474-12-245","volume":"12","author":"N Uceyler","year":"2011","unstructured":"Uceyler N, Hauser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011;12:245.","journal-title":"BMC Musculoskelet Disord"},{"key":"505_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1744806916662886","volume":"12","author":"N Stensson","year":"2016","unstructured":"Stensson N, et al. High levels of endogenous lipid mediators (N-acylethanolamines) in women with chronic widespread pain during acute tissue trauma. Mol Pain. 2016;12:1\u201311.","journal-title":"Mol Pain"},{"issue":"9","key":"505_CR44","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.pain.2013.05.002","volume":"154","author":"N Ghafouri","year":"2013","unstructured":"Ghafouri N, et al. Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity. Pain. 2013;154(9):1649\u201358.","journal-title":"Pain"},{"issue":"2","key":"505_CR45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33(2):160\u201372.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"505_CR46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1080\/00140139408963698","volume":"37","author":"K Ohlsson","year":"1994","unstructured":"Ohlsson K, et al. An assessment of neck and upper extremity disorders by questionnaire and clinical examination. Ergonomics. 1994;37(5):891\u20137.","journal-title":"Ergonomics"},{"issue":"5","key":"505_CR47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/AJP.0b013e31829e9d2a","volume":"30","author":"B Gerdle","year":"2014","unstructured":"Gerdle B, et al. Chronic widespread pain: increased glutamate and lactate concentrations in the trapezius muscle and plasma. Clin J Pain. 2014;30(5):409\u201320.","journal-title":"Clin J Pain"},{"key":"505_CR48","first-page":"306","volume":"7","author":"N Stensson","year":"2016","unstructured":"Stensson N, et al. Identification of lipid mediators in peripheral human tissues using an integrative in vivo microdialysis approach. J Anal Bioanal Tech. 2016;7:306.","journal-title":"J Anal Bioanal Tech"},{"issue":"14\u201315","key":"505_CR49","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jchromb.2009.04.010","volume":"877","author":"MG Balvers","year":"2009","unstructured":"Balvers MG, Verhoeckx KC, Witkamp RF. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(14\u201315):1583\u201390.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"505_CR50","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One. 2014;9(4):e95192.","journal-title":"PLoS One"},{"key":"505_CR51","doi-asserted-by":"crossref","first-page":"3874964","DOI":"10.1155\/2016\/3874964","volume":"2016","author":"A Moen","year":"2016","unstructured":"Moen A, et al. Inflammatory serum protein profiling of patients with lumbar radicular pain one year after disc herniation. Int J Inflam. 2016;2016:3874964.","journal-title":"Int J Inflam"},{"key":"505_CR52","doi-asserted-by":"crossref","unstructured":"Gerdle B, et al. Signs of inflammation in female patients with chronic widespread pain-a multivariat, explorative, cross-sectional study of blood samples. Med. 2017. in press.","DOI":"10.1097\/MD.0000000000006130"},{"issue":"3","key":"505_CR53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pain.2004.09.017","volume":"112","author":"L Rosendal","year":"2004","unstructured":"Rosendal L, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain. 2004;112(3):324\u201334.","journal-title":"Pain"},{"key":"505_CR54","volume-title":"Multi- and Megavariate data analysis; part I and II","author":"L Eriksson","year":"2006","unstructured":"Eriksson L, et al. Multi- and Megavariate data analysis; part I and II. 2nd ed. Ume\u00e5: Umetrics AB; 2006.","edition":"2"},{"issue":"11","key":"505_CR55","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1039\/c3mb70194h","volume":"9","author":"AM Wheelock","year":"2013","unstructured":"Wheelock AM, Wheelock CE. Trials and tribulations of \u2019omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine. Mol BioSyst. 2013;9(11):2589\u201396.","journal-title":"Mol BioSyst"},{"key":"505_CR56","volume-title":"Multi- and Megavariate data analysis: basic principles and applications","author":"L Eriksson","year":"2013","unstructured":"Eriksson L, et al. Multi- and Megavariate data analysis: basic principles and applications. Third revised edition ed. Malm\u00f6: MKS Umetrics AB; 2013.","edition":"Third revised e"},{"issue":"11\u201312","key":"505_CR57","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/cem.1187","volume":"22","author":"L Eriksson","year":"2008","unstructured":"Eriksson L, Trygg J, Wold S. CV-ANOVA for significance testing of PLS and OPLS\u00ae models. J Chemom. 2008;22(11\u201312):594\u2013600.","journal-title":"J Chemom"},{"issue":"5","key":"505_CR58","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.psyneuen.2008.02.009","volume":"33","author":"I Kaufmann","year":"2008","unstructured":"Kaufmann I, et al. Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology. 2008;33(5):676\u201385.","journal-title":"Psychoneuroendocrinology"},{"key":"505_CR59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12891-016-0951-9","volume":"17","author":"F Hellstrom","year":"2016","unstructured":"Hellstrom F, et al. Association between plasma concentrations of linoleic acid-derived oxylipins and the perceived pain scores in an exploratory study in women with chronic neck pain. BMC Musculoskelet Disord. 2016;17:103.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"505_CR60","first-page":"1366","volume":"35","author":"H Wang","year":"2008","unstructured":"Wang H, et al. Circulating cytokine levels compared to pain in patients with fibromyalgia -- a prospective longitudinal study over 6 months. J Rheumatol. 2008;35(7):1366\u201370.","journal-title":"J Rheumatol"},{"issue":"12","key":"505_CR61","doi-asserted-by":"crossref","first-page":"e0143856","DOI":"10.1371\/journal.pone.0143856","volume":"10","author":"N Christidis","year":"2015","unstructured":"Christidis N, et al. Comparison of the levels of pro-inflammatory cytokines released in the Vastus Lateralis muscle of patients with fibromyalgia and healthy controls during contractions of the quadriceps muscle--a microdialysis study. PLoS One. 2015;10(12):e0143856.","journal-title":"PLoS One"},{"key":"505_CR62","doi-asserted-by":"crossref","unstructured":"B\u00e4ckryd E, et al. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017. in press.","DOI":"10.2147\/JPR.S128508"},{"issue":"4","key":"505_CR63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbalip.2008.01.006","volume":"1781","author":"A Artmann","year":"2008","unstructured":"Artmann A, et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta. 2008;1781(4):200\u201312.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"505_CR64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/biof.1158","volume":"40","author":"K Kleberg","year":"2014","unstructured":"Kleberg K, Hassing HA, Hansen HS. Classical endocannabinoid-like compounds and their regulation by nutrients. Biofactors. 2014;40(4):363\u201372.","journal-title":"Biofactors"},{"key":"505_CR65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2014.03.006","volume":"86","author":"HS Hansen","year":"2014","unstructured":"Hansen HS. Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat. Pharmacol Res. 2014;86:18\u201325.","journal-title":"Pharmacol Res"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T15:08:45Z","timestamp":1659107325000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0505-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,12]]},"article-number":"112"}}